Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.

Código QR

Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.

Epstein Barr virus (EBV) infection expands CD8+ T cells specific for lytic antigens to high frequencies during symptomatic primary infection, and maintains these at significant numbers during persistence. Despite this, the protective function of these lytic EBV antigen-specific cytotoxic CD8+ T cell...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olga Antsiferova, Anne Müller, Patrick C Rämer, Obinna Chijioke, Bithi Chatterjee, Ana Raykova, Raquel Planas, Mireia Sospedra, Anatoliy Shumilov, Ming-Han Tsai, Henri-Jacques Delecluse, Christian Münz
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/e25caa9499d24c2d95619727227fe222
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.
por: Kevin Tsai, et al.
Publicado: (2011)

Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells.
por: J Luis Espinoza, et al.
Publicado: (2012)

Methodological bases of differential detection of the EBV1/EBV2 and HHV6A/HHV6B
por: M. Popkova, et al.
Publicado: (2019)

EBV Positive Aggressive NK-Cell Leukemia
por: Ankitha Hebbar, et al.
Publicado: (2021)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
por: Ya Cao
Publicado: (2017)

New Look of EBV LMP1 Signaling Landscape
por: Ling Wang, et al.
Publicado: (2021)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Tong Xiang, et al.
Publicado: (2018)

Determining molecular and genetic markers for severe EBV-mononucleosis
por: E. N. Filatova, et al.
Publicado: (2020)

HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China.
por: Xin Huang, et al.
Publicado: (2012)

HLA associations in classical Hodgkin lymphoma: EBV status matters.
por: Xin Huang, et al.
Publicado: (2012)

Associação do vírus Epstein-Barr (EBV) com tumores sólidos
por: Marcos Antonio Pereira de Lima, et al.
Publicado: (2006)

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
por: Jiang Li, et al.
Publicado: (2007)

Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
por: Jing Cai, et al.
Publicado: (2021)

EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis.
por: Séverine Vincent-Bugnas, et al.
Publicado: (2013)

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
por: Umaimainthan Palendira, et al.
Publicado: (2011)

Adoptive Cell Transfer of Allogeneic Epstein–Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report
por: Bjoern-Thore Hansen, et al.
Publicado: (2021)

PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
por: Hiroshi Nakano, et al.
Publicado: (2021)

Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Corey Smith, et al.
Publicado: (2021)

Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses
por: Haiwen Chen, et al.
Publicado: (2021)

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma
por: Weitao Lin, et al.
Publicado: (2018)

Complete intra-laboratory validation of a LAL assay for bacterial endotoxin determination in EBV-specific cytotoxic T lymphocytes
por: Salvatore Pasqua, et al.
Publicado: (2021)

EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity.
por: Nannan Zhu, et al.
Publicado: (2021)

Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis
por: Filipe Barcelos, et al.
Publicado: (2021)

Apoptosis- and survival-related gene mRNA profile in peripheral blood leukocytes in children with acute EBV infectious mononucleosis
por: N. A. Sakharnov, et al.
Publicado: (2020)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
por: Nicholas Van Sciver, et al.
Publicado: (2021)

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia
por: Mercedeh Movassagh, et al.
Publicado: (2019)

Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)—A Case Report
por: Montserrat Pazos, et al.
Publicado: (2021)

Epigenetic Regulation of Tumor Suppressors by <italic toggle="yes">Helicobacter pylori</italic> Enhances EBV-Induced Proliferation of Gastric Epithelial Cells
por: Saurabh Pandey, et al.
Publicado: (2018)

Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.
por: Guitao Zhang, et al.
Publicado: (2013)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
por: Chenhe Su, et al.
Publicado: (2021)

The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
por: Anna Shkoda, et al.
Publicado: (2012)

Two Pathways of p27<sup>Kip1</sup> Degradation Are Required for Murine Lymphoma Driven by Myc and EBV Latent Membrane Protein 2A
por: Richard P. Sora, et al.
Publicado: (2019)

Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients
por: Yanli Wang, et al.
Publicado: (2022)

Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
por: Caterina Foti, et al.
Publicado: (2021)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Elham Ahmadi, et al.
Publicado: (2021)

Erratum for Pandey et al., “Epigenetic Regulation of Tumor Suppressors by <named-content content-type="genus-species">Helicobacter pylori</named-content> Enhances EBV-Induced Proliferation of Gastric Epithelial Cells”
por: Saurabh Pandey, et al.
Publicado: (2020)

Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <italic toggle="yes">In Vivo</italic>”
por: Anita Murer, et al.
Publicado: (2019)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <italic toggle="yes">In Vivo</italic>
por: Anita Murer, et al.
Publicado: (2019)

Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.
por: Emily Heath, et al.
Publicado: (2012)